Effects of combined tamoxifen and medroxyprogesterone treatment on coagulation-fibrinolytic systems in patients with advanced breast cancer.
Fukutomi
T
T
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.
Adachi
I
I
Watanabe
T
T
Nanasawa
T
T
Yamamoto
H
H
D000368:Aged; D001777:Blood Coagulation / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use*
D013629:Tamoxifen; D008525:Medroxyprogesterone